HomeNewsTrendsHealthIf Rouhani's COVID-19 numbers are true, Iran is heading for herd immunity

If Rouhani's COVID-19 numbers are true, Iran is heading for herd immunity

So what this possibly means is that Iran may not need a COVID-19 vaccine - generally considered as fastest and surest way to reach herd immunity.

July 19, 2020 / 19:02 IST
Story continues below Advertisement
Representative image
Representative image

Iran’s President Hassan Rouhani on Saturday said that 2.5 crore Iranians have been infected with the COVID-19, and that another 3.5 crore are at risk of acquiring it.

Rouhani figures were based on a new Health Ministry report. Iran’s official toll is around 2.7 lakh cases and 13,979 deaths.

Story continues below Advertisement

There is a huge discrepancy between the numbers stated by Rouhani and Iran's official figures. There is still no clarity, whether Rouhani possibly messed up with the numbers or not.

But if it's true, now close to one-third of Iran's 8 crore population is infected, if the cases rise as per Rouhini's projection, Iran would be heading for  natural herd immunity, or it could be possible that some Iranian cities and towns, may already have sufficient infections for herd immunity.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show

Also Read: Older children spread the coronavirus just as much as adults, study finds
But we don't have any data related seroprevalence study, where  a sample of population is taken to see presence of the antibodies. Seroprevalance study helps to know about the percentage of people who have been infected with SARS-CoV-2.